Altamira's cancer treatment shows promise, shares soar

Altamira Therapeutics

19/07/2022 18:35

** Biotech co Altamira Therapeutics shares  CYTO.O  up 25%
to 57 cents - set for biggest daily percentage rise since April
2022
    ** Co's proprietary delivery platform SemaPhore showed
encouraging results for use in cancer therapy in a peer-reviewed
study  urn:newsml:reuters.com:*:nGNE238rbs
    ** Study compared eight different cell-penetrating peptides
for effectiveness in cellular uptake
    ** More than 48 mln shares traded, 100 times their 25-day
moving avg volume
    ** CYTO's stock had fallen ~69% vs a 25% decline in the
Nasdaq Composite Index  .IXIC 

 (Reporting by Johann M Cherian in Bengaluru)
 ((yohann.mcherian @thomsonreuters.com))